• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对“程-普鲁索夫”校正的精确校正。

An exact correction to the "Cheng-Prusoff" correction.

作者信息

Munson P J, Rodbard D

机构信息

Laboratory of Theoretical and Physical Biology, National Institute of Child Health and Human Development, Bethesda, Md 20892.

出版信息

J Recept Res. 1988;8(1-4):533-46. doi: 10.3109/10799898809049010.

DOI:10.3109/10799898809049010
PMID:3385692
Abstract

The use of graphical estimation techniques in pharmacology is well entrenched, yet can sometimes lead to confusion and errors. The widely used Cheng-Prusoff correction for obtaining the inhibition constant Ki from the graphical mid point or ED50 of a displacement or inhibition curve is not exact, contrary to popular belief. We show that under many commonly used experimental conditions, the Cheng-Prusoff rule can lead to a substantial 3- to 6-fold or larger error in the estimate of Ki. Surprisingly, an explicit, relatively simple exact correction rule is available. We derive this rule and show the conditions under which its use is required.

摘要

药理学中图形估计技术的应用已相当成熟,但有时也会导致混淆和错误。与普遍看法相反,广泛用于从位移或抑制曲线的图形中点或ED50获取抑制常数Ki的Cheng-Prusoff校正并不精确。我们表明,在许多常用的实验条件下,Cheng-Prusoff规则可能会导致Ki估计值出现高达3至6倍或更大的显著误差。令人惊讶的是,有一个明确、相对简单的精确校正规则。我们推导了这个规则,并展示了需要使用它的条件。

相似文献

1
An exact correction to the "Cheng-Prusoff" correction.对“程-普鲁索夫”校正的精确校正。
J Recept Res. 1988;8(1-4):533-46. doi: 10.3109/10799898809049010.
2
Linearization of two ligand-one binding site scatchard plot and the "IC50" competitive inhibition plot: application to the simplified graphical determination of equilibrium constants.
Life Sci. 1988;42(3):231-7. doi: 10.1016/0024-3205(88)90631-5.
3
The Cheng-Prusoff relationship: something lost in the translation.程-普鲁索夫关系:翻译中遗失的某些东西。
Trends Pharmacol Sci. 1993 Mar;14(3):89-91. doi: 10.1016/0165-6147(93)90070-z.
4
Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses.使用功能性组织反应应用程-普鲁索夫关系来估计阿托品亲和常数时相关的问题。
Life Sci. 1989;44(1):81-94. doi: 10.1016/0024-3205(89)90221-x.
5
The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.效能问题:从半数抑制浓度(IC50)确定平衡解离常数(KB)或抑制常数(Ki)。深入研究程-普鲁索夫方程、希尔德图及相关效能方程。
J Pharmacol Toxicol Methods. 2001 Sep-Oct;46(2):61-71. doi: 10.1016/s1056-8719(02)00166-1.
6
Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%.
J Cyclic Nucleotide Res. 1982;8(3):163-72.
7
Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation.从功能实验中的抑制曲线估算拮抗剂解离常数(Kb):替代程-普鲁索夫方程的方法
Trends Pharmacol Sci. 1993 Jun;14(6):237-9. doi: 10.1016/0165-6147(93)90018-f.
8
Further concerns over Cheng-Prusoff analysis.对程-普鲁索夫分析的进一步担忧。
Trends Pharmacol Sci. 1993 Apr;14(4):110-2. doi: 10.1016/0165-6147(93)90080-4.
9
Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.使用加德姆、希尔德和程-普鲁索夫方程从功能抑制曲线估计竞争性拮抗剂亲和力。
Br J Pharmacol. 1993 Aug;109(4):1110-9. doi: 10.1111/j.1476-5381.1993.tb13737.x.
10
The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.协同性对解离常数测定的影响:对程-普鲁索夫方程、斯卡查德分析、希尔分析及相关幂方程的考察
Pharmacol Res. 2004 Jul;50(1):21-40. doi: 10.1016/j.phrs.2003.11.007.

引用本文的文献

1
Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor.发现氯氮平(Clonixeril)作为人源STING受体的亚飞摩尔级调节剂。
ACS Cent Sci. 2025 Jun 6;11(6):994-1008. doi: 10.1021/acscentsci.4c01982. eCollection 2025 Jun 25.
2
Urea Denaturation, Zinc Binding, and DNA Binding Assays of Mutant p53 DNA-binding Domains and Full-length Proteins.突变型p53 DNA结合结构域和全长蛋白的尿素变性、锌结合及DNA结合分析
Bio Protoc. 2021 Oct 20;11(20):e4188. doi: 10.21769/BioProtoc.4188.
3
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.
锌塑造了 p53 的折叠景观,并为激活结构多样的癌症突变体建立了一条途径。
Elife. 2020 Dec 2;9:e61487. doi: 10.7554/eLife.61487.
4
MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.通过与β2-微球蛋白共价连接的肽裂解后交换评估 MHC-I 肽结合活性。
Anal Biochem. 2019 Nov 1;584:113328. doi: 10.1016/j.ab.2019.05.017. Epub 2019 Jun 13.
5
Substrate-assisted enzymatic formation of lysinoalanine in duramycin.赖氨酰琥珀酸酶辅助赖氨酰琥珀酸在 duramycin 中的酶促形成。
Nat Chem Biol. 2018 Oct;14(10):928-933. doi: 10.1038/s41589-018-0122-4. Epub 2018 Sep 3.
6
Discovery of 7-hydroxyaporphines as conformationally restricted ligands for beta-1 and beta-2 adrenergic receptors.发现7-羟基阿朴啡作为β-1和β-2肾上腺素能受体的构象受限配体。
Medchemcomm. 2018 Jan 22;9(2):353-356. doi: 10.1039/c7md00656j. eCollection 2018 Feb 1.
7
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).利用吡嗪蛋白降解探针(CCT367766)进行细胞内靶标结合验证。
J Med Chem. 2018 Feb 8;61(3):918-933. doi: 10.1021/acs.jmedchem.7b01406. Epub 2018 Jan 5.
8
Mechanistic enzymology in drug discovery: a fresh perspective.药物发现中的机制酶学:全新视角。
Nat Rev Drug Discov. 2018 Feb;17(2):115-132. doi: 10.1038/nrd.2017.219. Epub 2017 Dec 1.
9
Monitoring the Retention of Human Proliferating Cell Nuclear Antigen at Primer/Template Junctions by Proteins That Bind Single-Stranded DNA.通过结合单链DNA的蛋白质监测人增殖细胞核抗原在引物/模板连接处的保留情况。
Biochemistry. 2017 Jul 11;56(27):3415-3421. doi: 10.1021/acs.biochem.7b00386. Epub 2017 Jun 27.
10
Characterization of human translesion DNA synthesis across a UV-induced DNA lesion.紫外线诱导的DNA损伤处人类跨损伤DNA合成的表征
Elife. 2016 Oct 22;5:e19788. doi: 10.7554/eLife.19788.